Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021-2025).

Wang Y, Wang C, Ren F, Zhavoronkov A, Ding X

Open source

DOI
10.1080/13543776.2026.2674071
Published
2026 Jun
Container
Expert opinion on therapeutic patents
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/13543776.2026.2674071,
  title = {Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021-2025).},
  author = {Wang Y and Wang C and Ren F and Zhavoronkov A and Ding X},
  year = {2026},
  journal = {Expert opinion on therapeutic patents},
  doi = {10.1080/13543776.2026.2674071},
  url = {https://doi.org/10.1080/13543776.2026.2674071}
}

RIS

TY  - JOUR
TI  - Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021-2025).
AU  - Wang Y
AU  - Wang C
AU  - Ren F
AU  - Zhavoronkov A
AU  - Ding X
PY  - 2026
JO  - Expert opinion on therapeutic patents
DO  - 10.1080/13543776.2026.2674071
UR  - https://doi.org/10.1080/13543776.2026.2674071
ER  - 

APA

Y, W., C, W., F, R., A, Z., & X, D. (2026). Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021-2025).. Expert opinion on therapeutic patents. https://doi.org/10.1080/13543776.2026.2674071

Source records